申请人:THE SCRIPPS RESEARCH INSTITUTE
公开号:EP2913326A1
公开(公告)日:2015-09-02
Compounds that activate a sphingosine-1-phosphate receptor of the subtype 1 are provided. Certain compounds selectively activate the receptor subtype 1 in relation to the sphinogosine-1-phosphate receptor subtype 3. Uses and methods of inventive compounds for treatment of malconditions wherein activation, agonism, inhibition or antagonism of the S1P1 is medically indicated are provided.
本研究提供了能激活亚型 1 的鞘氨醇-1-磷酸受体的化合物。与鞘氨醇-1-磷酸受体亚型 3 相比,某些化合物可选择性地激活受体亚型 1。本发明提供了本发明化合物的用途和方法,用于治疗S1P1的激活、激动、抑制或拮抗在医学上有指示意义的不良病症。